Nuveen’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Nuveen’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-85,520	Closed	-$1.05M	–	3169
2022 Q4	$1.05M	Sell	85,520 -360	-0.4%	-$8.58K	﹤0.01%	2664
2022 Q3	$2.82M	Buy	85,880 +34,277	+66%	+$969K	﹤0.01%	2207
2022 Q2	$973K	Buy	51,603 +35,424	+219%	+$678K	﹤0.01%	2790
2022 Q1	$284K	Buy	+16,179	New	+$332K	﹤0.01%	3133

Nuveen's CINC Position: Q1 2023 in Review

Nuveen sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 85,520 shares — an estimated $1.05M sold.

Nuveen first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $2.82M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Nuveen reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Nuveen sold 85,520 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $1.05M.
Nuveen first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Nuveen's CinCor Pharma, Inc. Common Stock position peaked at $2.82M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.